An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial PneumoniasWilliam D. Travis, Dominique Valeyre, Masanori Kitaichi et al.|American Journal of Respiratory and Critical Care Medicine|2013Cited by 4.3k
Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesKevin R. Flaherty, Kevin K. Brown, Athol U. Wells et al.|New England Journal of Medicine|2019Cited by 2.3k
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U. Wells, Daniel F. Dilling, Kevin R. Flaherty et al.|The Lancet Respiratory Medicine|2020Cited by 558
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort studySimon Walsh, David M. Hansell, Athol U. Wells et al.|The Lancet Respiratory Medicine|2016Cited by 448
Idiopathic Interstitial PneumoniaKevin R. Flaherty, Fernando J. Martínez, Adin‐Cristian Andrei et al.|American Journal of Respiratory and Critical Care Medicine|2007Cited by 272